PAVmed CEO Secures 350,000 Shares in Long‑Term Grant—Insiders Show Confidence Amid Product Launches and New Subsidiary ?
Insider buying surge at PAVmed: CEO’s 350k‑share grant, CFO & execs’ 1.4M+ shares signal confidence, potential price lift, and future valuation impact. Read how this may shape investors’ decisions.
3 minutes to read


